- Home
- BOX vs GH Comparison
BOX vs GH Comparison
Compare BOX & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOX
- GH
- Stock Information
- Founded
- BOX 2005
- GH 2011
- Country
- BOX United States
- GH United States
- Employees
- BOX N/A
- GH N/A
- Industry
- BOX Computer Software: Prepackaged Software
- GH Medical Specialities
- Sector
- BOX Technology
- GH Health Care
- Exchange
- BOX Nasdaq
- GH Nasdaq
- Market Cap
- BOX 4.6B
- GH 4.9B
- IPO Year
- BOX 2015
- GH 2018
- Fundamental
- Price
- BOX $32.53
- GH $55.35
- Analyst Decision
- BOX Strong Buy
- GH Strong Buy
- Analyst Count
- BOX 9
- GH 17
- Target Price
- BOX $39.11
- GH $58.24
- AVG Volume (30 Days)
- BOX 2.3M
- GH 2.4M
- Earning Date
- BOX 08-26-2025
- GH 11-05-2025
- Dividend Yield
- BOX N/A
- GH N/A
- EPS Growth
- BOX 57.29
- GH N/A
- EPS
- BOX 1.25
- GH N/A
- Revenue
- BOX $1,125,704,000.00
- GH $828,849,000.00
- Revenue This Year
- BOX $8.52
- GH $28.07
- Revenue Next Year
- BOX $7.61
- GH $21.61
- P/E Ratio
- BOX $26.39
- GH N/A
- Revenue Growth
- BOX 6.29
- GH 28.74
- 52 Week Low
- BOX $28.00
- GH $20.14
- 52 Week High
- BOX $38.80
- GH $68.00
- Technical
- Relative Strength Index (RSI)
- BOX 51.06
- GH 41.67
- Support Level
- BOX $32.49
- GH $56.35
- Resistance Level
- BOX $33.60
- GH $61.95
- Average True Range (ATR)
- BOX 0.82
- GH 2.21
- MACD
- BOX 0.10
- GH -1.44
- Stochastic Oscillator
- BOX 53.18
- GH 6.93
About BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.